Abstract
Background
Recent data indicate that among patients undergoing percutaneous coronary intervention low platelet response to aspirin is associated with clopidogrel low response. It is unclear whether these findings extend to other patient populations. We, therefore, aimed to evaluate the relation between response to aspirin and clopidogrel among patients scheduled to undergo cardiac or vascular surgery.
Methods
Patients who were scheduled for cardiac or vascular surgery and had taken aspirin 81–325 mg daily for at least a week and clopidogrel 75 mg daily for at least 3 days underwent blood testing for platelet function. One hundred patients were included in the current analysis. Platelet function was evaluated by the modified TEG platelet mapping assay with addition of ADP or arachidonic acid (AA), and by the PFA-100 assay with collagen-epinephrine (CEPI) or collagen-ADP (CADP) cartridges. Low response to aspirin or clopidogrel was defined as inhibition ≤20% for TEG-AA or TEG-ADP, respectively.
Results
Thirteen patients (13%) were low responders to aspirin and 34 (34%) were low responders to clopidogrel. Eight patients were low responders to both drugs. There were no differences in clinical characteristics between drug low responders versus sensitive patients. Aspirin low responders had lower TEG-ADP inhibition (19.5 ± 6 vs. 35.8 ± 3%, P = 0.03) and tended to have lower PFA-CADP time (84.7 ± 7 vs. 105.6 ± 5 s, P = 0.1) than aspirin sensitive patients. Clopidogrel low responders had lower TEG-AA inhibition (58 ± 6 vs. 75.1 ± 4%, P = 0.01) and PFA-CEPI time (168 ± 13 vs. 200.4 ± 10 s, P = 0.07) than clopidogrel sensitive patients.
Conclusions
In patients scheduled to undergo cardiovascular surgery low response to aspirin is associated with low response to clopidogrel.
Similar content being viewed by others
References
Buchanan MR, Brister SJ (1995) Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically. Can J Cardiol 11:221–227
Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S (2002) Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105:1650–1655
Gurbel PA, Bliden KP, Hiatt BL, O’Connor CM (2003) Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 107:2908–2913
Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ (2005) Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 45:246–251
Lev E, Patel RT, Maresh KJ et al (2006) Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 47:27–33
Cuisset T, Frere C, Quilici J et al (2006) High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost 4:542–549
Craft RM, Chavez JJ, Bresee SJ, Wortham DC, Cohen E, Carroll RC (2004) A novel modification of the thromboelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 143:301–309
Craft RM, Chavez JJ, Snider CC, Muenchen RA, Carroll RC (2005) Comparison of modified thrombelastograph and plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med 145:309–315
Fontana P, Nolli S, Reber G, de Moerloose P (2006) Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 heal hy volunteers. J Thromb Haemost 4:813–819
Eikelboom JW, Hankey GJ et al (2005) Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial. J Thromb Haemost 3:2649–2655
Mathur A, Robinson MS, Cotton J, Martin JF, Erusalimsky JD (2001) Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behavior between unstable angina and myocardial infarction. Thromb Haemost 85:989–994
Harrison P, Mackie I, Mathur A et al (2005) Platelet hyper-function in acute coronary syndromes. Blood Coagul Fibrinolysis 16:557–562
Coulter SA, Cannon CP, Ault KA et al (2000) High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14. Circulation 101:2690–2695
Macchi L, Christiaens L, Brabant S et al (2002) Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate. Thromb Res 107:45–49
Kawasaki T, Ozeki Y, Igawa T, Kambayashi J (2000) Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin. Stroke 31:591–595
Guthikonda S, Lev EI, Patel R et al (2006) Aspirin resistance is strongly associated with increased platelet turnover. J Thromb Haemost (in press)
Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W (2000) Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 110:965–967
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E et al (2004) PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation. Blood Coagul Fibrinolysis 15:89–93
Tantry US, Bliden KP, Gurbel PA (2005) Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol 46:1705–1709
Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ (2003) A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41:961–965
Matetzky S, Shenkman B, Guetta V et al (2004) Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulatio 109:3171–3175
Muller I, Besta F, Schulz C, Massberg S, Schonig A, Gawaz M (2003) Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 89:783–787
Chen WH, Lee PY, Ng W, Tse HF, Lau CP (2004) Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43:1122–1126
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lev, E.I., Ramchandani, M., Garg, R. et al. Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery. J Thromb Thrombolysis 24, 15–21 (2007). https://doi.org/10.1007/s11239-007-0008-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-007-0008-x